Since the creation of AIA Trial Proceedings in 2012, parties have filed more than 11,500 petitions to the Patent Trial and Appeal Board (“PTAB”). Today, these proceedings and the PTAB are a significant aspect of every major patent litigation. Yet, the contours of these proceedings continue to change.
MBHB partners James Lovsin and George “Trey” Lyons, III will take a look at these topics and more and the impact they have on AIA Trial Proceedings, including:
- Discretionary Denials: What are Patent Owner strategies for obtaining discretionary denials?
- What are Petitioner strategies for avoiding them?
- Motions to Amend: What benefit (or not) does the Patent Owner get for participating in the motion to amend pilot program?
- Can the Petitioner rely on the PTAB to present its own grounds to oppose the motions to amend?
- What are strategies for § 101 challenges to motions to amend?
- Constitutionality: What are the updates and potential outcomes/impacts from Supreme Court action in Arthrex?
- Appealability: What procedural issues are reviewable after Thryv and Windy City?
Title:
Webinar Date+Time:
Wednesday, November 18, 2020
11:00 am Eastern Standard Time
10:00 am
Central Standard Time
8:00 am
Pacific Standard Time
Speakers:
MBHB attorney(s) James Lovsin and George “Trey” Lyons, III
Cost:
While there is no fee to participate, all attendees must register in advance and, in order to receive MCLE credit, must participate online and individually.
Credit:
MCLE credit is pending for the states of California, Illinois, New Jersey,* New York,* North Carolina and Virginia (*via reciprocity).
You may be able to self-apply for credit in other jurisdictions.
By:
McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.
In this free Continuing Legal Education course you will learn of advanced online legal research methods to harness your potential as a researcher and to maintain that competency.
In this webinar, experts in medicine, health care law, and bioethics will discuss potential COVID vaccination policies. 
Zoom Meeting - please register using this link before the meeting begins
Title: 
Title:
In this webinar, tech-focused private equity and capital markets experts will report on recent trends in investment, exit strategies, deal structures and deal terms. They will look at recent developments from the perspectives of target companies and investors, highlighting financings, M&A and public listings (whether by IPO, direct listing or reverse merger with a SPAC). Our experts will also consider how venture capital and private equity are managing their technology investments during the pandemic downturn and the rationales behind how and when tech investors decide to make their exits.
Join Bloomberg Law for this 60-minute, CLE-Eligible webinar focused on key consideration in tech exits.
Educational Objectives:
Get updated on market developments in the technology sector
Understand new trends in tech deal structures and terms
Learn about what is special concerns of tech companies and investors in the pandemic
Who would benefit most from attending this program? 
